Quick Answer
Dolby Laboratories, Inc. reported Cash and Equivalents of $701.89 million for fiscal year 2025.
Dolby Laboratories, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $701.89M | +45.6% |
| 2024 | $482.05M | -35.3% |
| 2023 | $745.36M | +20.2% |
| 2022 | $620.13M | -49.4% |
| 2021 | $1.23B | +14.3% |
| 2020 | $1.07B | +34.5% |
| 2019 | $797.21M | -13.2% |
| 2018 | $918.06M | +44.7% |
| 2017 | $634.37M | +22.1% |
| 2016 | $519.76M | -2.3% |
| 2015 | $531.93M | -6.4% |
| 2014 | $568.47M | +25.1% |
| 2013 | $454.40M | -7.8% |
| 2012 | $492.60M | -10.7% |
| 2011 | $551.51M | +1.0% |
| 2010 | $545.86M | +20.9% |
| 2009 | $451.68M | +14.4% |
| 2008 | $394.76M | +7.1% |
| 2007 | $368.47M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $643.85M | +23.6% | -8.3% |
| September 30, 2025 | $701.89M | +45.6% | +0.5% |
| June 30, 2025 | $698.57M | -5.8% | +11.5% |
| March 31, 2025 | $626.55M | -11.7% | +20.3% |
| December 31, 2024 | $520.82M | -20.7% | +8.0% |
| September 30, 2024 | $482.05M | -35.3% | -35.0% |
| June 30, 2024 | $741.64M | -3.1% | +4.5% |
| March 31, 2024 | $709.53M | +3.1% | +8.0% |
- Dolby Laboratories, Inc. showed an increase of +45.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, Dolby Laboratories, Inc.’s cash and equivalents has grown by 90.5% (from $368.47 million to $701.89 million).
- The most recent figure is from Dolby Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: